MYCOBACTERIUM - ANVISA Registration 10338930301
Access comprehensive regulatory information for MYCOBACTERIUM in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10338930301 and manufactured by OXFORD IMMUNOTEC LTD. The registration is held by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA with validity until Sep 17, 2028.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including HAIN LIFESCIENCE GMBH, BECTON DICKINSON AND COMPANY (SPARKS), and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamRelated Devices (2)
Registration Details
10338930301
25351799577202318
93741726000166
Company Information
Dates and Status
Dec 18, 2023
17/09/2028
09/18/2025 19:00:01
MYCOBACTERIUM
QuantiFERON®-TB GOLD Plus (QFT® Plus)
Not specified
10322250071
Sep 05, 2016
MYCOBACTERIUM
QuantiFERON®-TB GOLD Plus (QFT® Plus)
QIAGEN GMBH
10322250071
Sep 05, 2016
MYCOBACTERIUM
AFIAS IGRA-TB
Not specified
10350840460
Jul 22, 2024
MYCOBACTERIUM
AFIAS IGRA-TB
BODITECH MED INC.
10350840460
Jul 22, 2024
MYCOBACTERIUM
VIDAS® TB-IGRA (TBRA)
BIOMERIEUX SA
10158120735
Oct 18, 2021
MYCOBACTERIUM
RIDA® TB Tubes
R-BIOPHARM AG
82890930018
Sep 15, 2025
MYCOBACTERIUM
RIDA® TB Tubes
Not specified
82890930018
Sep 15, 2025
MYCOBACTERIUM
RIDA®QUICK TB
Not specified
82890930015
Jul 07, 2025
MYCOBACTERIUM
RIDA®QUICK TB
R-BIOPHARM AG
82890930015
Jul 07, 2025
MYCOBACTERIUM
RIDASCREEN® TB
R-BIOPHARM AG
82890930012
Jun 23, 2025